Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Sushil Kumar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5552-2039; OpenAlex author ID A5101437333. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2025: 1 paper

Papers 1

  1. Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer. Last author DOI 10.1038/s41698-025-01046-w↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hareesh B Nair · 1 shared paper, 2025 · strength 0.21
  2. Parthasarathy Seshacharyulu · 1 shared paper, 2025 · strength 0.21
  3. Namita Bhyravbhatla · 1 shared paper, 2025 · strength 0.21
  4. Shailendra Kumar Gautam · 1 shared paper, 2025 · strength 0.21
  5. Xiaoqi Li Li · 1 shared paper, 2025 · strength 0.21
  6. Zahraa Wajih Alsafwani · 1 shared paper, 2025 · strength 0.21
  7. Rick Bhatia · 1 shared paper, 2025 · strength 0.21
  8. Mokenge Peter Malafa · 1 shared paper, 2025 · strength 0.21
  9. Surinder K. Batra · 1 shared paper, 2025 · strength 0.21
  10. Maneesh Jain · 1 shared paper, 2025 · strength 0.21
  11. Moorthy Palanimuthu Ponnusamy · 1 shared paper, 2025 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.